FDB and Polyglot Systems Partner to Help Improve Medication Adherence

First Databank (FDB), a provider of clinical drug knowledge that helps improve medication-related decisions and patient outcomes,has entered into an agreement with Polyglot Systems to be the primary distributor of Polyglot’s proprietary Meducation® simplified patient medication instructions to the hospital, ambulatory, and pharmacy markets in the United States and Canada.

Read More »

Common Vaccine Error Leaves Patients Unprotected

The Institute for Safe Medication Practices (ISMP) has received frequent reports of errors involving vaccine administration to a patient where only one of two necessary vaccine components supplied is administered. These errors leave patients unprotected against serious and sometimes fatal communicable diseases.

Read More »

System Secures, Tracks Medication Deliveries Sent Through Existing Pneumatic Tube Delivery Systems

Aethon Inc. has unveiled a patent-pending system that secures and tracks medication deliveries sent through a hospital’s existing pneumatic tube system and guarantees medication is delivered to authorized personnel. Pneumatic tube systems are used extensively to deliver medications through hospitals. Yet, missing or delayed doses cost the hospital millions of dollars in lost productivity, inventory, and safety concerns.

Read More »

The Impact of Interruptions and Distractions on Hospital Pharmacies: A Review with Recommendations

The impact of interruptions and distractions (I&Ds) on efficiency and safety is well documented across multiple industries. Within healthcare, studies about the impact of I&Ds have focused primarily on medical and nursing practice. To date there has been limited attention devoted to the impact of I&Ds on pharmacy flow and safety, which presents a significant opportunity to make a difference.

Read More »

HHS Seeks Feedback for Draft of National Action Plan for Adverse Drug Event Prevention

Adverse drug events are the largest contributor to hospital-related complications and account for more than 3.5 million physician office visits each year. As a result of increased attention to reduce and prevent the dangers associated with adverse drug events, the U.S. Department of Health & Human Services (HHS), in partnership with the U.S. Department of Defense, U.S. Department of Veterans Affairs, and the U.S. Bureau of Prisons has developed the National Action Plan for Adverse Drug Event Prevention.

Read More »